Wekerle H - Search Results

1

MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47.

Junker A, Krumbholz M, Eisele S, Mohan H, Augstein F, Bittner R, Lassmann H, Wekerle H, Hohlfeld R, Meinl E. Junker A, et al. Among authors: wekerle h. Brain. 2009 Dec;132(Pt 12):3342-52. doi: 10.1093/brain/awp300. Brain. 2009. PMID: 19952055

2

Drug insight: using monoclonal antibodies to treat multiple sclerosis.

Hohlfeld R, Wekerle H. Hohlfeld R, et al. Among authors: wekerle h. Nat Clin Pract Neurol. 2005 Nov;1(1):34-44. doi: 10.1038/ncpneuro0016. Nat Clin Pract Neurol. 2005. PMID: 16932490 Review.

3

Multiple sclerosis: T-cell receptor expression in distinct brain regions.

Junker A, Ivanidze J, Malotka J, Eiglmeier I, Lassmann H, Wekerle H, Meinl E, Hohlfeld R, Dornmair K. Junker A, et al. Among authors: wekerle h. Brain. 2007 Nov;130(Pt 11):2789-99. doi: 10.1093/brain/awm214. Epub 2007 Sep 21. Brain. 2007. PMID: 17890278

4

Extracellular matrix in multiple sclerosis lesions: Fibrillar collagens, biglycan and decorin are upregulated and associated with infiltrating immune cells.

Mohan H, Krumbholz M, Sharma R, Eisele S, Junker A, Sixt M, Newcombe J, Wekerle H, Hohlfeld R, Lassmann H, Meinl E. Mohan H, et al. Among authors: wekerle h. Brain Pathol. 2010 Sep;20(5):966-75. doi: 10.1111/j.1750-3639.2010.00399.x. Epub 2010 Mar 25. Brain Pathol. 2010. PMID: 20456365 Free PMC article.

5

Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination.

Mohan H, Friese A, Albrecht S, Krumbholz M, Elliott CL, Arthur A, Menon R, Farina C, Junker A, Stadelmann C, Barnett SC, Huitinga I, Wekerle H, Hohlfeld R, Lassmann H, Kuhlmann T, Linington C, Meinl E. Mohan H, et al. Among authors: wekerle h. Acta Neuropathol Commun. 2014 Dec 11;2:168. doi: 10.1186/s40478-014-0168-9. Acta Neuropathol Commun. 2014. PMID: 25589163 Free PMC article.

6

The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets.

Hohlfeld R, Dornmair K, Meinl E, Wekerle H. Hohlfeld R, et al. Among authors: wekerle h. Lancet Neurol. 2016 Feb;15(2):198-209. doi: 10.1016/S1474-4422(15)00334-8. Epub 2015 Dec 24. Lancet Neurol. 2016. PMID: 26724103 Review.

7

Human astrocytes are only partially competent antigen presenting cells. Possible implications for lesion development in multiple sclerosis.

Weber F, Meinl E, Aloisi F, Nevinny-Stickel C, Albert E, Wekerle H, Hohlfeld R. Weber F, et al. Among authors: wekerle h. Brain. 1994 Feb;117 ( Pt 1):59-69. doi: 10.1093/brain/117.1.59. Brain. 1994. PMID: 7511974

8

Multiple sclerosis. Immunomodulatory effects of human astrocytes on T cells.

Meinl E, Aloisi F, Ertl B, Weber F, de Waal Malefyt R, Wekerle H, Hohlfeld R. Meinl E, et al. Among authors: wekerle h. Brain. 1994 Dec;117 ( Pt 6):1323-32. doi: 10.1093/brain/117.6.1323. Brain. 1994. PMID: 7820569

9

Immunological update on multiple sclerosis.

Hohlfeld R, Wekerle H. Hohlfeld R, et al. Among authors: wekerle h. Curr Opin Neurol. 2001 Jun;14(3):299-304. doi: 10.1097/00019052-200106000-00006. Curr Opin Neurol. 2001. PMID: 11371751 Review.

10

BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma.

Krumbholz M, Theil D, Derfuss T, Rosenwald A, Schrader F, Monoranu CM, Kalled SL, Hess DM, Serafini B, Aloisi F, Wekerle H, Hohlfeld R, Meinl E. Krumbholz M, et al. Among authors: wekerle h. J Exp Med. 2005 Jan 17;201(2):195-200. doi: 10.1084/jem.20041674. Epub 2005 Jan 10. J Exp Med. 2005. PMID: 15642740 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

320 results

Search Page